Literature DB >> 18971484

Genetic dissection of gamma-secretase-dependent and -independent functions of presenilin in regulating neuronal cell cycle and cell death.

Verena Kallhoff-Munoz1, Lingyun Hu, Xiaoli Chen, Robia G Pautler, Hui Zheng.   

Abstract

Cell cycle markers have been shown to be upregulated and proposed to lead to apoptosis of postmitotic neurons in Alzheimer's disease (AD). Presenilin (PS) plays a critical role in AD pathogenesis, and loss-of-function studies in mice established a potent effect of PS in cell proliferation in peripheral tissues. Whether PS has a similar activity in the neuronal cell cycle has not been investigated. PS exhibits gamma-secretase-dependent and -independent functions; the former requires aspartate 257 (D257) as part of the active site, and the latter involves the hydrophilic loop domain encoded by exon 10. We used two novel mouse models, one expressing the PS1 D257A mutation on a postnatal PS conditional knock-out background and the other deleting exon 10 of PS1, to dissect the gamma-secretase-dependent and -independent activities of PS in the adult CNS. Whereas gamma-secretase plays a dominant role in neuronal survival, our studies reveal potent neuronal cell cycle regulation mediated by the PS1 hydrophilic loop. Although neurons expressing cell cycle markers do not directly succumb to apoptosis, they are more vulnerable under stress conditions. Importantly, our data identify a novel pool of cytoplasmic p53 as a downstream mediator of this cellular vulnerability. These results support a model whereby the PS gamma-secretase activity is essential in maintaining neuronal viability, and the PS1 loop domain modulates neuronal homeostasis through cell cycle and cytoplasmic p53 control.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18971484      PMCID: PMC2615184          DOI: 10.1523/JNEUROSCI.2873-08.2008

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  48 in total

1.  The C-terminal fragment of presenilin 2 triggers p53-mediated staurosporine-induced apoptosis, a function independent of the presenilinase-derived N-terminal counterpart.

Authors:  Cristine Alves da Costa; Mark P Mattson; Karine Ancolio; Frederic Checler
Journal:  J Biol Chem       Date:  2003-01-29       Impact factor: 5.157

Review 2.  The presenilin hypothesis of Alzheimer's disease: evidence for a loss-of-function pathogenic mechanism.

Authors:  Jie Shen; Raymond J Kelleher
Journal:  Proc Natl Acad Sci U S A       Date:  2006-12-29       Impact factor: 11.205

3.  Deficient neurogenesis in forebrain-specific presenilin-1 knockout mice is associated with reduced clearance of hippocampal memory traces.

Authors:  R Feng; C Rampon; Y P Tang; D Shrom; J Jin; M Kyin; B Sopher; M W Miller; C B Ware; G M Martin; S H Kim; R B Langdon; S S Sisodia; J Z Tsien
Journal:  Neuron       Date:  2001-12-06       Impact factor: 17.173

4.  Activation of caspase-3 in developmental models of programmed cell death in neurons of the substantia nigra.

Authors:  B S Jeon; N G Kholodilov; T F Oo; S Y Kim; K J Tomaselli; A Srinivasan; L Stefanis; R E Burke
Journal:  J Neurochem       Date:  1999-07       Impact factor: 5.372

5.  BrdU assay for neurogenesis in rodents.

Authors:  J Martin Wojtowicz; Nohjin Kee
Journal:  Nat Protoc       Date:  2006       Impact factor: 13.491

6.  Loss of presenilin 1 is associated with enhanced beta-catenin signaling and skin tumorigenesis.

Authors:  X Xia; S Qian; S Soriano; Y Wu; A M Fletcher; X J Wang; E H Koo; X Wu; H Zheng
Journal:  Proc Natl Acad Sci U S A       Date:  2001-08-21       Impact factor: 11.205

7.  Regulation of tyrosinase trafficking and processing by presenilins: partial loss of function by familial Alzheimer's disease mutation.

Authors:  Runsheng Wang; Phuong Tang; Pei Wang; Raymond E Boissy; Hui Zheng
Journal:  Proc Natl Acad Sci U S A       Date:  2005-12-29       Impact factor: 11.205

8.  The aspartate-257 of presenilin 1 is indispensable for mouse development and production of beta-amyloid peptides through beta-catenin-independent mechanisms.

Authors:  Xuefeng Xia; Pei Wang; Xiaoyan Sun; Salvador Soriano; Wan-Kyng Shum; Haruyasu Yamaguchi; Myrna E Trumbauer; Akihiko Takashima; Edward H Koo; Hui Zheng
Journal:  Proc Natl Acad Sci U S A       Date:  2002-06-17       Impact factor: 11.205

9.  Loss of neuronal cell cycle control as a mechanism of neurodegeneration in the presenilin-1 Alzheimer's disease brain.

Authors:  Bilal Malik; Antonio Currais; Ana Andres; Christopher Towlson; Didier Pitsi; Ana Nunes; Michael Niblock; Jonathan Cooper; Tibor Hortobágyi; Salvador Soriano
Journal:  Cell Cycle       Date:  2007-12-06       Impact factor: 4.534

10.  Dentate gyrus volume is reduced before onset of plaque formation in PDAPP mice: a magnetic resonance microscopy and stereologic analysis.

Authors:  Jeffrey M Redwine; Barry Kosofsky; Russell E Jacobs; Dora Games; John F Reilly; John H Morrison; Warren G Young; Floyd E Bloom
Journal:  Proc Natl Acad Sci U S A       Date:  2003-01-24       Impact factor: 11.205

View more
  4 in total

1.  NSAIDs prevent, but do not reverse, neuronal cell cycle reentry in a mouse model of Alzheimer disease.

Authors:  Nicholas H Varvel; Kiran Bhaskar; Maria Z Kounnas; Steven L Wagner; Yan Yang; Bruce T Lamb; Karl Herrup
Journal:  J Clin Invest       Date:  2009-11-09       Impact factor: 14.808

Review 2.  Reassessing the amyloid cascade hypothesis of Alzheimer's disease.

Authors:  Sanjay W Pimplikar
Journal:  Int J Biochem Cell Biol       Date:  2008-12-30       Impact factor: 5.085

3.  Increased adult neurogenesis associated with reactive astrocytosis occurs prior to neuron loss in a mouse model of neurodegenerative disease.

Authors:  Ting-Ting Liu; Xiao-Lian Ye; Jin-Ping Zhang; Ting-Ting Yu; Shan-Shan Cheng; Xiao-Chuan Zou; Yun Xu; Gui-Quan Chen; Zhen-Yu Yin
Journal:  CNS Neurosci Ther       Date:  2017-09-27       Impact factor: 5.243

4.  Cell cycle checkpoint abnormalities during dementia: A plausible association with the loss of protection against oxidative stress in Alzheimer's disease [corrected].

Authors:  Pavel Katsel; Weilun Tan; Peter Fam; Dushyant P Purohit; Vahram Haroutunian
Journal:  PLoS One       Date:  2013-07-05       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.